Choon‐Kee Lee
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 4
- Hematology 13
- Multiple Myeloma Research and Treatments 13
- Co-authors
- Guido Tricot (9 shared papers)Bart Barlogie (10 shared papers)Maurizio Zangari (9 shared papers)Athanasios Fassas (8 shared papers)Bolin Liu (8 shared papers)Shuiliang Wang (7 shared papers)Elias Anaissie (6 shared papers)Frits van Rhee (4 shared papers)
- Journals
- Blood (5 papers)British Journal of Haematology (4 papers)Cancer Letters (3 papers)Clinical Infectious Diseases (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Choon‐Kee Lee
19 papers receiving 920 citations
Peers
Comparison fields: 5 of 71
- Hematology 598
- Internal Medicine 86
- Oncology 454
- Genetics 113
- Molecular Biology 541
Countries citing papers authored by Choon‐Kee Lee
This map shows the geographic impact of Choon‐Kee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choon‐Kee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choon‐Kee Lee more than expected).
Fields of papers citing papers by Choon‐Kee Lee
This network shows the impact of papers produced by Choon‐Kee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choon‐Kee Lee. The network helps show where Choon‐Kee Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Choon‐Kee Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 168 | |
| 2 | 2005 | 146 | |
| 3 | 2003 | 133 | |
| 4 | 2002 | 119 | |
| 5 | 2002 | 60 | |
| 6 | 2009 | 56 | |
| 7 | 2010 | 45 | |
| 8 | 2013 | 42 | |
| 9 | 2011 | 36 | |
| 10 | 2004 | 29 | |
| 11 | 2004 | 25 | |
| 12 | 2013 | 25 | |
| 13 | 2011 | 19 | |
| 14 | 2003 | 11 | |
| 15 | Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells. | 2013 | 11 |
| 16 | 2004 | 9 | |
| 17 | 2005 | 2 | |
| 18 | 2004 | 2 | |
| 19 | 2012 | 1 |
About Choon‐Kee Lee
Choon‐Kee Lee is a scholar working on Molecular Biology, Hematology, Oncology, Infectious Diseases and Surgery, having authored 19 papers that have together received 939 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (4 papers), Bone health and treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Hematology (598 citations), Internal Medicine (86 citations), Oncology (454 citations), Genetics (113 citations) and Molecular Biology (541 citations). Choon‐Kee Lee has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Guido Tricot, Bart Barlogie, Maurizio Zangari, Athanasios Fassas, Bolin Liu, Shuiliang Wang, Elias Anaissie, Frits van Rhee, Firas Muwalla and Xiaoping Huang. Their work appears in journals such as Blood, British Journal of Haematology, Cancer Letters, Clinical Infectious Diseases and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.